4.3 Article

Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Physiology

The 'neuroadrenergic hypothesis' in hypertension: current evidence

Guido Grassi et al.

EXPERIMENTAL PHYSIOLOGY (2010)

Article Clinical Neurology

Sustained reduction of hypertension by deep brain stimulation

Erlick A. C. Pereira et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2010)

Review Neurosciences

Central sympathetic overactivity: Maladies and mechanisms

James P. Fisher et al.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2009)

Article Peripheral Vascular Disease

Baroreflex device therapy in the treatment of hypertension

Sarada C. Uppuluri et al.

CURRENT HYPERTENSION REPORTS (2009)

Article Peripheral Vascular Disease

Newly Reported Hypertension After Military Combat Deployment in a Large Population-Based Study

Nisara S. Granado et al.

HYPERTENSION (2009)

Article Endocrinology & Metabolism

Differential Effects of Chlorthalidone Versus Spironolactone on Muscle Sympathetic Nerve Activity in Hypertensive Patients

Dileep V. Menon et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)

Article Neurosciences

Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans

Colin N. Young et al.

JOURNAL OF PHYSIOLOGY-LONDON (2009)

Article Behavioral Sciences

Sympathetic nervous system behavior in human obesity

Kevin P. Davy et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2009)

Article Medicine, General & Internal

SHATTUCK LECTURE The Hypertension Paradox - More Uncontrolled Disease despite Improved Therapy

Aram V. Chobanian

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Letter Medicine, General & Internal

Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension.

Markus P. Schlaich et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Pharmacology & Pharmacy

Chronic mental stress is a cause of essential hypertension: Presence of biological markers of stress

Murray Esler et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)

Article Peripheral Vascular Disease

Exercise training restores baroreflex sensitivity in never-treated hypertensive patients

Mateus C. Laterza et al.

HYPERTENSION (2007)

Article Pharmacology & Pharmacy

Exercise training and sympathetic nervous system activity: Evidence for physical activity dependent neural plasticity

Patrick J. Mueller

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)

Review Pharmacology & Pharmacy

Clinical pharmacology and therapeutic use of antioxidant vitamins

Ramon Rodrigo et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)

Letter Cardiac & Cardiovascular Systems

Statins and sympathetic nerve activity in heart failure

Irving H. Zucker et al.

JOURNAL OF CARDIAC FAILURE (2006)

Article Peripheral Vascular Disease

Arterial baroreceptor input contributes to long-term control of blood pressure

Terry N. Thrasher

CURRENT HYPERTENSION REPORTS (2006)

Article Peripheral Vascular Disease

Reactive oxygen species in the neuropathogenesis of hypertension

Jeffrey R. Peterson et al.

CURRENT HYPERTENSION REPORTS (2006)

Article Cardiac & Cardiovascular Systems

Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension

H Krum et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)

Article Endocrinology & Metabolism

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome

NE Straznicky et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)

Article Peripheral Vascular Disease

Prolonged activation of the baroreflex: A viable approach for the treatment of hypertension?

TE Lohmeier et al.

CURRENT HYPERTENSION REPORTS (2005)

Review Physiology

Exercise training and sympathetic regulation in experimental heart failure

IH Zucker et al.

EXERCISE AND SPORT SCIENCES REVIEWS (2004)

Review Pharmacology & Pharmacy

Sympathetic and baroreflex function in hypertension: Implications for current and new drugs

G Grassi

CURRENT PHARMACEUTICAL DESIGN (2004)

Review Cardiac & Cardiovascular Systems

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

RH Böger

CARDIOVASCULAR RESEARCH (2003)

Article Cardiac & Cardiovascular Systems

Weight loss improves neurovascular and muscle metaboreflex control in obesity

IC Trombetta et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)

Article Physiology

Statin therapy restores sympathovagal balance in experimental heart failure

RU Pliquett et al.

JOURNAL OF APPLIED PHYSIOLOGY (2003)

Article Cardiac & Cardiovascular Systems

Simvastatin normalizes autonomic neural control in experimental heart failure

RU Pliquett et al.

CIRCULATION (2003)

Article Medicine, General & Internal

Nitric oxide deficiency as a cause of clinical hypertension - Promising new drug targets for refractory hypertension

GD Thomas et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)

Article Endocrinology & Metabolism

Body mass index and the prevalence of hypertension and dyslipidemia

CD Brown et al.

OBESITY RESEARCH (2000)

Article Peripheral Vascular Disease

Adrenergic and reflex abnormalities in obesity-related hypertension

G Grassi et al.

HYPERTENSION (2000)

Article Peripheral Vascular Disease

Rilmenidine: A clinical overview

JL Reid

AMERICAN JOURNAL OF HYPERTENSION (2000)